8I8 Stock Overview
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 6/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Integrated Diagnostics Holdings plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.32 |
52 Week High | US$0.51 |
52 Week Low | US$0.23 |
Beta | 0.49 |
1 Month Change | 30.65% |
3 Month Change | 10.96% |
1 Year Change | -19.40% |
3 Year Change | -61.52% |
5 Year Change | n/a |
Change since IPO | -63.64% |
Recent News & Updates
Recent updates
Shareholder Returns
8I8 | DE Healthcare | DE Market | |
---|---|---|---|
7D | -4.7% | -1.8% | 1.6% |
1Y | -19.4% | -2.3% | 6.4% |
Return vs Industry: 8I8 underperformed the German Healthcare industry which returned -2% over the past year.
Return vs Market: 8I8 underperformed the German Market which returned 6.4% over the past year.
Price Volatility
8I8 volatility | |
---|---|
8I8 Average Weekly Movement | 10.3% |
Healthcare Industry Average Movement | 5.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8I8's share price has been volatile over the past 3 months.
Volatility Over Time: 8I8's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1979 | 6,718 | Hend El Sherbini | https://www.idhcorp.com |
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria.
Integrated Diagnostics Holdings plc Fundamentals Summary
8I8 fundamental statistics | |
---|---|
Market cap | €215.89m |
Earnings (TTM) | €10.48m |
Revenue (TTM) | €75.10m |
20.7x
P/E Ratio2.9x
P/S RatioIs 8I8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8I8 income statement (TTM) | |
---|---|
Revenue | ج.م3.86b |
Cost of Revenue | ج.م2.44b |
Gross Profit | ج.م1.42b |
Other Expenses | ج.م879.70m |
Earnings | ج.م538.46m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.90 |
Gross Margin | 36.75% |
Net Profit Margin | 13.96% |
Debt/Equity Ratio | 3.6% |
How did 8I8 perform over the long term?
See historical performance and comparison